## KHC: The Kraft Heinz Company - XLP: Consumer Defensive

### Executive Summary

No thesis match: MRS_10 -0.2% below STRENGTH zone (3.0-6.0%). Stock is in no-man's land without clear edge. Caution: momentum weakening (-1.8% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($23.67)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 8
- **Sentiment:** Bullish (Bullish: 2, Bearish: 0)

**1. Kraft Heinz Shuffles Executive Deck in Advance of Spin-offs**
- Source: Meatingplace | 20251217T200817 | Neutral | Relevance: 100%
- The Kraft Heinz Co. has appointed Steve Cahillane as CEO, effective January 1, ahead of its planned separation into two independent companies. Cahillane, who previously led Kellanova and Nature's Bounty Co., will later become CEO of the Global Taste Elevation Co. The company's executive suite is preparing for the split into Global Taste Elevation Co. and North American Grocery Co. in the second half of 2026.

**2. Kraft Heinz Names Former Kellanova Exec Steve Cahillane as CEO**
- Source: FoodEngineeringMag.com | 20251218T160824 | Bullish | Relevance: 100%
- The Kraft Heinz Company has appointed Steve Cahillane as its new CEO, effective January 1, 2026. Cahillane will also join the Board of Directors and lead Global Taste Elevation Co. after Kraft Heinz's planned separation into two independent companies. He previously served as Chairman, President, and CEO of Kellanova, bringing extensive experience in the food and beverage industry to his new role.

**3. Eastman, AstraZeneca, Kraft Heinz, and P&G Recognized with OMP Supply Chain Awards**
- Source: USA Today | 20251217T162557 | Bullish | Relevance: 93%
- Eastman, AstraZeneca, Kraft Heinz, and P&G were honored at the OMP Conference for their significant contributions to supply chain planning innovation and excellence. Eastman received the Long-Term Partnership Award for co-shaping Unison Planning™, AstraZeneca earned the Innovation Award for AI-driven planning, and Kraft Heinz and P&G were recognized with the Excellence Award for their sustained commitment to advancing digital supply chain planning. The awards highlight these companies' leadership in setting new industry benchmarks and driving real-world results.

**4. How protein powers CPG majors’ expansion plans**
- Source: DairyReporter.com | 20251219T165350 | Somewhat-Bullish | Relevance: 64%
- Protein remains a critical driver of innovation and portfolio expansion for major CPG companies like Danone, PepsiCo, and General Mills. These companies are strategically leveraging high-protein products, including dairy and plant-based options, to meet consumer demand for health, wellness, and weight management, thereby fueling their growth and financial performance. They are implementing product reformulations, new launches, and capacity expansions to capitalize on this mainstream wellness trend.

**5. Why Hormel is struggling to profit off America’s protein obsession**
- Source: Star Tribune | 20251217T120100 | Neutral | Relevance: 63%
- Hormel, a company synonymous with pork and other protein products, is struggling to capitalize on America's protein obsession despite expanding its offerings. High input costs for products like pork bellies and unforeseen events like a peanut butter facility fire and avian flu outbreaks have eroded profits, causing Hormel's stock to drop. Despite these challenges, Hormel's sales have edged up, and the company is focusing on leveraging its diverse protein portfolio and traditional food sources, while analysts predict a stronger performance in 2026 due to anticipated lower costs.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-15 | Piper Sandler | $27 | $25 | +8% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-15 | Piper Sandler | main | Neutral |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 1 ($0.00M) |
| Sells | 0 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 57.1% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 4 |

**Top Holders:**
- Berkshire Hathaway, : 27.5% (0.0%)
- Vanguard Group Inc: 8.6% (-0.1%)
- Blackrock Inc.: 7.6% (-7.4%)
- State Street Corpora: 3.9% (-0.6%)
- Geode Capital Manage: 2.3% (+3.5%)

### Key Risks

1. Long-term trend broken: trading 9.2% below SMA200.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.00 indicates undervaluation relative to growth. Analyst sentiment positive (1 raises, avg +8%). Institutional flow bullish (5 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $29.0B |
| Beta | 0.07 |
| 52W Range | $23.70 - $33.35 |
| Short Interest | 6.3% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.00 |
| Forward P/E | 9.7 |
| Current P/E | 9.7 |
| YoY Growth | -0.6% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from 1.6% to -0.2% (-1.8% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 3.2pp (needs >3.0% for momentum thesis). Below SMA200 (0.91x), long-term trend not supportive. RSI neutral at 44. OFD pattern: -MTH (Decline).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -0.18% (CS: 51) | Neutral |
| RSI_14 | 44.5 | Neutral |
| MACD Histogram | 0.01 | Bullish |
| vs SMA20 | 0.987x | Below |
| vs SMA50 | 0.985x | Below |
| vs SMA200 | 0.908x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $24.51
- **Stop Loss:** $23.67 (3.4% risk)
- **Target:** $25.35 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 1428
- **Position Value:** $35,000.28
- **Portfolio %:** 35.00%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 120% | L2 100% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with improving risk appetite as VIX falls to 6th percentile and tech rally resumes on AI infrastructure demand. Fed pause expectations from cooling CPI data support equities, though elevated put/call ratio suggests cautious positioning. Focus on quality names in AI-exposed sectors.*

### Earnings

**Next:** 2026-02-11 (Est: $0.61)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.58 | $0.61 | +5.8% |
| 2025Q2 | $0.64 | $0.69 | +8.4% |
| 2025Q1 | $0.60 | $0.62 | +3.1% |
| 2024Q4 | $0.78 | $0.84 | +7.8% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*